Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
Clinical trial NCT04299880 · COMPLETED
Trial details
- NCT number
- NCT04299880
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2021-05-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.